Shenzhen-based Ming Capital leads final close of Series D in Belgian firm Miracor Medical

Shenzhen-based Ming Capital leads final close of Series D in Belgian firm Miracor Medical

Medical equipment in an operating theatre

Miracor Medical SA, a Belgian medical device company targeting cardiac ailments, has announced the final close of its Series D investment round of €30 million ($34.9 million) led by Shenzhen based venture capital firm Ming Capital and a strategic investor, according to a company release.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter